임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

13건 표시

1상모집 중단 (진행 중)· Pneumonia, Bacterial
Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years
리드: GSK
상세 →NCT07428759
1상모집 중단 (진행 중)· Hepatitis B
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
리드: GSK
상세 →NCT07168356
1상모집 중단 (진행 중)· Kidney Disease
A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease
리드: GSK
상세 →NCT06734234
1상모집 중단 (진행 중)· Colitis, Ulcerative
A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants
리드: GSK
상세 →NCT06681181
1상모집 중단 (진행 중)· Respiratory Syncytial Virus Infections
A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years
리드: GSK
상세 →NCT06573281
1상모집 중단 (진행 중)· Pulmonary Disease, Chronic Obstructive
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
리드: GSK
상세 →NCT06154837
1상모집 중단 (진행 중)· Neoplasms
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
리드: GSK
상세 →NCT05277051
1상모집 중단 (진행 중)· Anatomic Stage III Breast Cancer AJCC v8
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
협력: GSK
상세 →NCT04673448
1상모집 중단 (진행 중)· Multiple Myeloma
A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function
리드: GSK
상세 →NCT04398745
1상모집 중단 (진행 중)· Advanced Solid Tumor
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer
협력: GSK
상세 →NCT04502602
1상모집 중단 (진행 중)· Neoplasms
Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors
리드: GSK
상세 →NCT04446351
1상모집 중단 (진행 중)· Multiple Myeloma
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
리드: GSK
상세 →NCT04091126
1상모집 중단 (진행 중)· Neoplasms
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
리드: GSK
상세 →NCT03843359

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.